Get the Stockscreener App
4.84
0.21%
0.010
After Hours:
4.84
Armata Pharmaceuticals Inc stock is traded at $4.84, with a volume of 65,414.
It is up +0.21% in the last 24 hours and up +55.13% over the past month.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections in the United States. The company develops its products using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company is also developing and advancing synthetic phage for treating diseases caused by pseudomonas aeruginosa. Armata Pharmaceuticals, Inc. is headquartered in Marina del Rey, California.
See More
Previous Close:
$4.83
Open:
$4.68
24h Volume:
65,414
Relative Volume:
0.28
Market Cap:
$175.35M
Revenue:
-
Net Income/Loss:
$-41.36M
P/E Ratio:
-2.9512
EPS:
-1.64
Net Cash Flow:
$-42.09M
1W Performance:
-3.01%
1M Performance:
+55.13%
6M Performance:
+236.79%
1Y Performance:
+105.96%
1-Day Range:
$4.6613
$5.03
1-Week Range:
$4.65
$5.5897
52-Week Range:
$0.8981
$16.34
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
Name
Armata Pharmaceuticals Inc
Sector
Industry
Phone
310-655-2928
Address
4503 Glencoe Avenue, Marina del Rey, CA
Compare ARMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARMP
Armata Pharmaceuticals Inc
|
4.84 | 174.99M | 0 | -41.36M | -42.09M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-19-19 | Initiated | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc Stock (ARMP) Latest News
Will Armata Pharmaceuticals Inc. outperform the marketEarnings Recap Report & Technical Confirmation Trade Alerts - newser.com
How risky is Armata Pharmaceuticals Inc. stock compared to peersTrade Analysis Report & Real-Time Volume Surge Alerts - newser.com
Is Armata Pharmaceuticals Inc. stock a buy before earnings results2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com
What is the fair value estimate for Armata Pharmaceuticals Inc. stock in 2025Options Play & Low Volatility Stock Recommendations - newser.com
Why Armata Pharmaceuticals Inc. stock is a strong buy callJuly 2025 Outlook & Technical Pattern Alert System - newser.com
Custom watchlist performance reports with Armata Pharmaceuticals Inc.Rate Hike & Low Risk Investment Opportunities - newser.com
Can Armata Pharmaceuticals Inc. stock retain market dominanceTreasury Yields & Stepwise Trade Signal Guides - newser.com
How to use a screener to detect Armata Pharmaceuticals Inc. breakoutsWeekly Investment Recap & Free Growth Oriented Trading Recommendations - newser.com
Comparing Armata Pharmaceuticals Inc. in custom built stock radars2025 Key Highlights & Safe Entry Zone Tips - newser.com
Will Armata Pharmaceuticals Inc. stock go up soon2025 Biggest Moves & Community Trade Idea Sharing Platform - newser.com
Why Armata Pharmaceuticals Inc. (TG1N) stock attracts HNW investorsJuly 2025 Analyst Calls & Verified Stock Trade Ideas - newser.com
How to forecast Armata Pharmaceuticals Inc. trends using time seriesJuly 2025 Fed Impact & Free Community Supported Trade Ideas - newser.com
Is Armata Pharmaceuticals Inc. (TG1N) stock among top earnings playsPortfolio Update Summary & Proven Capital Preservation Methods - newser.com
Can Armata Pharmaceuticals Inc. stock sustain revenue momentumJuly 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com
How Armata Pharmaceuticals Inc. stock performs in rising dollar environment2025 Geopolitical Influence & Consistent Profit Trade Alerts - newser.com
Can Armata Pharmaceuticals Inc. stock rebound after recent weaknessMarket Volume Summary & Real-Time Buy Zone Alerts - newser.com
Will Armata Pharmaceuticals Inc. (TG1N) stock see insider accumulationJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com
Is Armata Pharmaceuticals Inc. (TG1N) stock testing key supportJuly 2025 Update & Safe Entry Point Alerts - newser.com
How Armata Pharmaceuticals Inc. (TG1N) stock performs during market turbulencePortfolio Risk Report & Stepwise Entry and Exit Trade Signals - newser.com
Will Armata Pharmaceuticals Inc. stock deliver consistent dividendsDollar Strength & Low Drawdown Momentum Trade Ideas - newser.com
Can Armata Pharmaceuticals Inc. stock sustain market leadershipJuly 2025 Pullbacks & Pattern Based Trade Signal System - newser.com
Forecasting Armata Pharmaceuticals Inc. price range with options data2025 Earnings Surprises & Daily Technical Stock Forecast Reports - newser.com
Real time scanner hits for Armata Pharmaceuticals Inc. explainedJuly 2025 Movers & Daily Oversold Bounce Ideas - newser.com
Can trapped investors hope for a rebound in Armata Pharmaceuticals Inc.July 2025 Action & Weekly High Potential Alerts - newser.com
Identifying reversal signals in Armata Pharmaceuticals Inc.July 2025 Momentum & Fast Gain Swing Alerts - newser.com
Why Armata Pharmaceuticals Inc. stock fits value portfoliosJuly 2025 Decliners & Weekly Top Gainers Alerts - newser.com
Is Armata Pharmaceuticals Inc. (TG1N) stock in buy zone after pullbackJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
What insider purchases suggest about Armata Pharmaceuticals Inc. stock2025 Pullback Review & Daily Stock Trend Reports - newser.com
Will Armata Pharmaceuticals Inc. stock recover after recent dropWeekly Market Report & Weekly Top Gainers Alerts - newser.com
Is Armata Pharmaceuticals Inc a good long term investmentAutomated Trading Signals & Free Explosive Return Secrets - earlytimes.in
Will Armata Pharmaceuticals Inc. stock justify high valuationMarket Trend Report & High Win Rate Trade Alerts - newser.com
Is Armata Pharmaceuticals Inc. building a consolidation baseWeekly Trade Recap & Risk Controlled Swing Trade Alerts - newser.com
Armata Pharmaceuticals Inc Stock (ARMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):